AlphaGrep UK
EW icon

AlphaGrep UK’s Edwards Lifesciences EW Stock Holding History

AlphaGrep UK’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$361K Buy
+4,184
New +$372K 0.11% 399

Other funds holding EW

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

AlphaGrep UK's EW Position: Q3 2026 in Review

AlphaGrep UK opened a new position in Edwards Lifesciences (EW) in Q3 2026: 4,184 shares worth $361K. The stake represents 0.11% of the portfolio and ranks #399 among its holdings.

1,141 funds tracked by Wall St. Rank hold EW as of Q3 2026.

  • AlphaGrep UK held 4,184 shares of Edwards Lifesciences worth $361K as of Q3 2026.
  • Edwards Lifesciences was a new AlphaGrep UK position in Q3 2026.
  • Edwards Lifesciences made up 0.11% of AlphaGrep UK's portfolio in Q3 2026, its #399 holding.
  • 1,141 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on AlphaGrep UK's 13F filing for Q3 2026, filed 12 Nov 2026.